Search Results - "Vistisen, Kirsten K."

Geriatric assessment and intervention in older vulnerable patients undergoing surgery for colorectal cancer: a protocol for a randomised controlled trial (GEPOC trial) by Dolin, Troels G, Mikkelsen, Marta, Jakobsen, Henrik L, Nordentoft, Tyge, Pedersen, Trine S, Vinther, Anders, Zerahn, Bo, Vistisen, Kirsten K, Suetta, Charlotte, Nielsen, Dorte, Johansen, Julia S, Lund, Cecilia M

“…The incidence of colorectal cancer (CRC) increases with age. Older patients are a heterogeneous group ranging from fit to frail with various comorbidities…”
Get full text

Myocardial Ischemia Induced by 5‐Fluorouracil: A Prospective Electrocardiographic and Cardiac Biomarker Study by Dyhl‐Polk, Anne, Schou, Morten, Vistisen, Kirsten K., Sillesen, Anne‐Sophie, Serup‐Hansen, Eva, Faber, Jens, Klausen, Tobias W., Bojesen, Stig E., Vaage‐Nilsen, Merete, Nielsen, Dorte L.

“…Background Cardiotoxicity induced by 5‐fluorouracil (5‐FU) is well known but poorly understood. In this study, we undertook ECG recording (Holter) and analyses…”
Get full text

Age-dependent differences in first-line chemotherapy in patients with metastatic colorectal cancer: the DISCO study by Lund, Cecilia M, Vistisen, Kirsten K, Dehlendorff, Christian, Rønholt, Finn, Johansen, Julia S, Nielsen, Dorte L

“…First-line chemotherapy for metastatic colorectal cancer (mCRC) is effective and feasible in selected older patients. We investigated age-dependent differences…”
Get more information

Capecitabine and Oxaliplatin Before, During, and After Radiotherapy for High-Risk Rectal Cancer by Larsen, Finn Ole, Markussen, Alice, Jensen, Benny V., Fromm, Anne L., Vistisen, Kirsten K., Parner, Vibeke K., Linnemann, Dorte, Hansen, Rasmus H., Johannesen, Helle H., Schou, Jakob V.

“…Treatment with capecitabine and oxaliplatin before, during, and after radiotherapy for high-risk rectal cancer is safe and feasible. It results in a good rate…”
Get full text